Abivax Sa · EURONEXT:ABVX
Invus Public Equities, L.P. reported a 6.00% stake in Abivax Sa (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 13, 2026
Invus Public Equities, L.P. reported a 6.00% stake in Abivax Sa, 4,790,187 shares, as a passive investor on Jun 30, 2026. Filed Aug 13, 2026 (Schedule 13G/A).
- Stake
- 6.00%
- Shares
- 4,790,187
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 8 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Invus Public Equities, L.P. | 6.00% | 4,790,187 |
| Invus Public Equities Advisors, LLC | 6.00% | 4,790,187 |
| Invus Global Management, LLC | 6.00% | 4,790,187 |
| Siren, L.L.C. | 6.00% | 4,790,187 |
| Avicenna Life Sci Master Fund LP | 0% | 35,572 |
| Avicenna Life Sci Master GP LLC | 0% | 35,572 |
| Ulys, L.L.C. | 0% | 35,572 |
| Raymond Debbane | 6.00% | 4,825,759 |
Source
Related
- Abivax Sa
- Invus Public Equities, L.P.
- Abivax Sa shareholders
- Schedule 13G/A · Invus Public Equities, L.P. · Feb 13, 2026
- Schedule 13G · Invus Public Equities, L.P. · Apr 11, 2025
- AMF threshold crossing notice · The Goldman Sachs Group, Inc. · Oct 16, 2026
- AMF threshold crossing notice · The Goldman Sachs Group, Inc. · Oct 15, 2026
- AMF threshold crossing notice · Bank of America Corporation · Oct 15, 2026
- AMF directors' dealing declaration · Marc De Garidel · Oct 14, 2026
- AMF directors' dealing declaration · Marc De Garidel · Oct 13, 2026